QUINLAN PAUL T (General Counsel and Secretary) sold 25.0% of their position (10K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $936.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+10K
Price / share
$7.80
Trade value
$78K
% of position
Common Stock
Shares
−2.90K
Price / share
$92.37
Trade value
$267.87K
% of position
Common Stock
Shares
−3.83K
Price / share
$93.32
Trade value
$357.59K
% of position
Common Stock
Shares
−601.00
Price / share
$94.44
Trade value
$56.76K
% of position
Common Stock
Shares
−2.67K
Price / share
$95.31
Trade value
$254.20K
% of position
Net shares
+0.00
Net value
-$858.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/21/2026 | M · Option Exercise | +10K | $7.80 | $78K | 33.3% | 30K | 39.99K |
| Common Stock Direct | 9/21/2026 | S · Sale | −2.90K | $92.37 | $267.87K | 7.3% | 39.99K | 37.09K |
| Common Stock Direct | 9/21/2026 | S · Sale | −3.83K | $93.32 | $357.59K | 10.3% | 37.09K | 33.26K |
| Common Stock Direct | 9/21/2026 | S · Sale | −601.00 | $94.44 | $56.76K | 1.8% | 33.26K | 32.66K |
| Common Stock Direct | 9/21/2026 | S · Sale | −2.67K | $95.31 | $254.20K | 8.2% | 32.66K | 30K |
| Total | +0.00 | -$858.42K | ||||||
Employee Warrant (right to buy)
Common Stock
10K shares
Shares
−10K
Strike price
7.8
Held after
80K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock10K shares | 9/21/2026 | M · Option Exercise | −10K | 7.8 | — | 80K |